Synthetic genome engineering forging new frontiers for wine yeast

Critical Reviews in Biotechnolgy

Opening new frontiers in wine yeast

Critical Reviews in Biotechnolgy

  • Topped our upper estimate! Evolva raises CHF 86M ($86M). Cash position now > CHF 100M ($100M). https://t.co/aiPI46jsTK

Sign up to receive our
Press Releases!

Sign up